Study of Psyllium 6.8 g Versus Placebo on Satiety in Healthy Volunteers
Randomized, Double-blind, Placebo-controlled, 2-treatment, 3-period Crossover Design Study of the Efficacy and Tolerability of Psyllium 6.8 g Provided as Sugarfree Metamucil® Fiber Supplement Powder Versus Placebo on Satiety in Healthy Volunteers
1 other identifier
interventional
45
1 country
1
Brief Summary
This is a randomized, double-blind, placebo-controlled, 2-treatment, 3-period crossover design study to evaluate the effects of psyllium 6.8 g provided as sugarfree Metamucil fiber supplement powder dissolved in water versus placebo on satiety measures in healthy volunteers. This study will be conducted at a single study site.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2013
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2013
CompletedFirst Submitted
Initial submission to the registry
March 11, 2013
CompletedFirst Posted
Study publicly available on registry
March 13, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2013
CompletedOctober 28, 2014
March 1, 2013
1 month
March 11, 2013
October 27, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
satiety (VAS Hunger 3-day average)
VAS Hunger 3-day average. This endpoint will be calculated by averaging all evaluable post-breakfast scores across Days 1, 2, and 3. VAS Hunger is assessed on a horizontal 100-mm VAS anchored on the left by the phrase "Not at all hungry" (score = 0) and on the right by "As hungry as I have ever felt" (score = 100).
Hours 0-4.5
Secondary Outcomes (5)
Satiety Labeled Intensity Magnitude (SLIM) 3-day average
Hours 0-4.5
VAS Desire to Eat 3-day average
Hours 0-4.5
VAS Hunger 3-day average for hours 3.0 - 4.5
Hours 3.0 - 4.5
SLIM 3-day average for Hours 3.0-4.5
Hours 3.0-4.5
VAS Desire to Eat 3-day average for hours 3.0 - 4.5
Hours 3.0-4.5
Study Arms (2)
psyllium fiber 6.8g
EXPERIMENTALTwo (2) packets Metamucil Orange Sugar Free Fiber Singles (psyllium 6.8 g) thoroughly mixed in Ten (10) ounces of water. Subjects will drink their assigned test product as quickly as possible immediately before eating breakfast at each visit.
placebo
PLACEBO COMPARATOROne (1) level teaspoon of placebo product thoroughly mixed in Ten (10) ounces of water. Subjects will drink their assigned test product as quickly as possible immediately before eating breakfast at each visit.
Interventions
Subjects will drink their assigned test product as quickly as possible immediately before eating breakfast at each visit.
Subjects will drink their assigned test product as quickly as possible immediately before eating breakfast at each visit.
Eligibility Criteria
You may qualify if:
- Subjects who meet all of the following criteria are eligible to participate in the study:
- routinely eat breakfast daily;
- agree to eat 100% of the food provided during the study, drink 10 ounces of water with the test product immediately before breakfast, and only eat a light snack after dinner before fasting overnight beginning at 10:00 PM prior to the next visit;
- have a screening VAS Hunger score \> 50 before eating breakfast that moves towards less hunger after eating breakfast;
- have 1-2 bowel movements per day that are typically rated as 3, 4, or 5 on the Bristol Stool Form Scale;
- in good general health based on medical history;
- if female, be postmenopausal or if of child-bearing capacity agree to use an adequate form of contraception (eg, surgical sterilization, birth control pills, birth control implants, condoms AND spermicide, abstinence);
- have a body mass index (BMI) ≥ 18.5 but \< 28 kg/m2;
- able to fulfill the requirements of the protocol and provide written consent;
- willing to abstain from any weight control or satiety supplements during the study;
- willing to refrain from taking any psyllium containing products or fiber supplements during the study with the exception of the test products;
- willing to maintain lifestyle habits for the duration of the study (eg, do not change exercise habits or begin a weight loss diet);
- willing to refrain from exercise on the mornings prior to arriving at the study site;
- willing to abstain from alcohol for 2 days prior to the first day of each test period through the last day of each test period;
- willing not to consume caffeine for 24 hours prior to the first day of each test period through the last day of each test period.
You may not qualify if:
- Subjects will be excluded from the study if they meet any of the following criteria:
- have any history of heart, liver, kidney, nerve, blood disorder, or cancer(except for treated basal cell cancer with a documented 6-month remission), or metabolic, hormone, or gastrointestinal (GI) disease;
- have a history of an eating disorder;
- have difficulty swallowing;
- have a history of gastrointestinal surgery (except appendectomy) or gastrointestinal bleeding;
- are currently alcohol or chemically dependent (a urine test for drugs of abuse will be given);
- report use of tobacco, smoking cessation products, or products containing nicotine within 3 months;
- have a significant psychiatric disorder;
- any use of prescription drugs, with the exception of birth control pills, within 14 days prior to the study or antibiotics in the past 30 days;
- any use of non-prescription drugs within 7 days prior to the study;
- used psyllium containing products or fiber supplements within the past month;
- have a history of phenylketonuria (PKU);
- have a history of a severe allergic reaction to psyllium;
- are currently on a structured formal diet (eg, Jenny Craig, Atkins);
- typically drink more than 70 ounces of liquid during the day (ie, approximately 4 bottles of water, each 16.9 ounces)
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Study Center
Cincinnati, Ohio, 45227, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jose Brum, MD
Procter and Gamble
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 11, 2013
First Posted
March 13, 2013
Study Start
March 1, 2013
Primary Completion
April 1, 2013
Study Completion
April 1, 2013
Last Updated
October 28, 2014
Record last verified: 2013-03